Enveric Biosciences ENVB
NASDAQ ENVB
$1.46 -0.01 (-0.68%)
As of: Sep 29, 2026 · 3:58 PM EDT

Enveric Biosciences (ENVB) Non-Current Assets (2011 - 2026)

Updated

Enveric Biosciences (ENVB) posted Non-Current Assets of $150,674 for Q2 2026, down 37.5% from $241,082 a year earlier but up 2.9% from the prior quarter.

Analysis

Enveric Biosciences (ENVB) Non-Current Assets (2011 - 2026) Analysis & Trends

At the end of FY2025, Enveric Biosciences' Non-Current Assets came in at $159,234, down 54.2% from FY2024.

  • Annual Non-Current Assets has declined for four consecutive years, with a five-year compound annual growth rate of -38.6% (FY2020 to FY2025).
  • In prior years, Enveric Biosciences' Non-Current Assets was $347,959 in FY2024 (-51.6%), $718,309 in FY2023 (-35.9%), $1.12 million in FY2022 (-87.5%) and $8.98 million in FY2021 (+394.2%).
  • Quarterly Non-Current Assets has run from a low of $146,365 in Q1 2026 to a high of $47.48 million in Q3 2021 over five years.
  • On a year-over-year basis, Non-Current Assets has declined in each of the last 16 quarters, with an average decline of 50.0% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q4 2021, with growth of 394.2%; the weakest was Q3 2023, with a decline of 90.8%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $146,365 (Q1 2026), $159,234 (Q4 2025) and $196,521 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 141.29 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 101.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 125.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 94.68 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 87.87 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 60.68 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 35.42 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 159.77 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 14.88 Bn
10 Enveric Biosciences 5.86 Mn -15.78 Mn - 150,674.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 150,674.00
Mar 31, 2026 146,365.00
Dec 31, 2025 159,234.00
Sep 30, 2025 196,521.00
Jun 30, 2025 241,082.00
Mar 31, 2025 267,279.00
Dec 31, 2024 347,959.00
Sep 30, 2024 452,057.00
Jun 30, 2024 531,670.00
Mar 31, 2024 620,972.00
Dec 31, 2023 718,309.00
Sep 30, 2023 792,272.00
Jun 30, 2023 900,151.00
Mar 31, 2023 1.01 Mn
Dec 31, 2022 1.12 Mn
Sep 30, 2022 8.59 Mn
Jun 30, 2022 9.20 Mn
Mar 31, 2022 9.51 Mn
Dec 31, 2021 8.98 Mn
Sep 30, 2021 47.48 Mn
API Access

Enveric Biosciences Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=ENVB&period=max&api_key=YOUR_API_KEY